Biological markers in epidemiology: Concepts, applications, perspectives (Part I);Biologische marker in der epidemiologie: Begriffe, anwendungen, perspektiven (Teil I)

Gesundheitswesen

Volumn 64, Issue 2, 2002, Pages 99-107

  Hoffmann, Wolfgang ^a   Latza, U ^a   Ahrens, W ^a   Greiser, K H ^a   Kroke, A ^a   Nieters, A ^a   Schulze, M B ^a   Steiner, M ^a   Terschuren C ^a   Wjst, M ^a  

^a UNIVERSITY OF BREMEN   (Germany)

Author keywords

Biomarker; Biomonitoring; Epidemiology; Future use; Genetic marker

Indexed keywords

BIOLOGICAL MARKER;

ARTICLE; BIOLOGICAL MONITORING; DISEASE COURSE; DISEASE MARKER; EPIDEMIOLOGY; EXPOSURE; GENETIC MARKER; MEDICAL RESEARCH; QUALITY CONTROL; RELIABILITY; VALIDATION PROCESS;

BIOLOGICAL MARKERS; ENVIRONMENTAL MONITORING; EPIDEMIOLOGIC STUDIES; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; RISK FACTORS;

EID: 0036176670     PISSN: 09413790     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2002-20274     Document Type: Article

References (90)

1. A conceptual and historical framework for molecular epidemiology
2. Commentary: Causal thinking, biomarkers, and mechanisms of carcinogenesis
3. Towards an integrated approach to molecular epidemiology
4. The next state: Molecular epidemiology
5. Biomarkers in pediatric environmental health: A cross-cutting issue
6. Molecular epidemiology: Focus on infection
7. The value of the Wassermann reaction in obstetrics based upon the study of 4547 consecutive cases
8. Determination of nicotine and cotinine in human serum and urine: An interlaboratory study
9. Humanbiomonitoring: Definitionen, möglichkeiten und voraussetzungen
10. Konzept der referenz- und Human-Biomonitoring-(HBM)-werte in der umweltmedizin
11. Deutsche forschungsgemeinschaft - Biological monitoring
12. Studiendesigns in der genetischen epidemiologie
13. Human genome epidemiologic reviews: The beginning of something HuGE
14. The molecular epidemiology of influenza
15. Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: The Atherosclerosis Risk in Communities (ARIC) study, 1987-1993
16. Increased common carotid intima-media thickness. Adaptive response or a reflection of atherosclerosis? Findings from the Rotterdam study
17. Serum cholesterol, lipoproteins, and the risk of coronary heart disease. The Framingham study
18. Cholesterol in the prediction of atherosclerotic disease. New perspectives based on the Framingham study
19. Some uses of prospective observations in the Tecumseh Community Health study
20. Diet, serum cholesterol, and death from coronary heart disease. The Western Electric study
21. Relationship of baseline serum cholesterol levels in 3 large cohorts of younger men to long-term coronary, cardiovascular, and all-cause mortality and to longevity
22. Serum cholesterol and mortality from coronary heart disease in young, middle-aged, and older men and women from three Chicago epidemiologic studies
23. Coronary disease mortality and risk factors in black and white men. Results from the combined Charleston, SC, and Evans County, Georgia, heart studies
24. The nature of pre-beta (very low density) lipoproteins
25. Fat transport in lipoproteins - An integrated approach to mechanisms and disorders, part I
26. Fat transport in lipoproteins - An integrated approach to mechanisms and disorders, part II (continued)
27. Fat transport in lipoproteins - An integrated approach to mechanisms and disorders, part III (continued)
28. Fat transport in lipoproteins - An integrated approach to mechanisms and disorders, part IV (continued)
29. Fat transport in lipoproteins - An integrated approach to mechanisms and disorders, part V (concluded)
30. The Framingham study: Its 50-year legacy and future promise
31. High density lipoprotein as a protective factor against coronary heart disease. The Framingham study
32. Lipids, diabetes, and coronary heart disease: Insights from the Framingham study
33. High density lipoprotein cholesterol, total cholesterol screening, and myocardial infarction. The Framingham study
34. Classical risk factors and their impact on incident non-fatal and fatal myocardial infarction and all-cause mortality in southern Germany
35. Diagnosis and management of hyperlipoproteinemia. Progress report
36. The Friedewald-Levy-Fredrickson formula for calculating low-density lipoprotein cholesterol, the basis for lipid-lowering therapy
37. Serum cholesterol in man: Diet fat and intrinsic responsiveness
38. Scoring system for evaluating dietary pattern effect on serum cholesterol
39. Review of clinical trials: Proving the lipid hypothesis
40. Association of high-density-lipoprotein cholestrol with mortality and other risk factors for major chronic noncommunicable diseases in samples of US and Russian men
41. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults
42. Elevated plasma lipoproteine (a) and coronary heart disease in men aged 55 years and younger. A prospective study
43. The Atherosclerosis Risk in Communities (ARIC) study: Design and objectives
44. B-scan ultrasound examination of the carotid arteries with a representative population (MONICA Project Augsburg)
45. Determinanten atherosklerotischer plaques in den karotis- und femoralarterien
46. Determinants of disease and disability in the elderly. The Rotterdam Elderly study
47. Methods for quality assurance of medical examination in epidemiological field studies: The "Study of Health in Pomerania" (SHIP)
48. Determinants of carotid intima-media thickness: A population-based ultrasonography study in eastern Finnish men
49. Aortic calcification as a predictor of cardiovascular mortality
50. Risk factors and coronary artery disease for asymptomatic women using electron beam computed tomography
51. Differential coronary artery calcification detected by electron beam computed tomography as an indicator of coronary stenosis among patients with stable angina pectoris
52. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart study
53. Attenuated cortisol response to a standardized stress test in Lithuanian versus Swedish men: The LiVicordia study
54. Cotinine as a biomarker of environmental tobacco smoke exposure
55. Measures of exposure to environmental tabacco smoke. Validity, precision, and relevance
56. Biomonitoring exposure to environmental tobacco smoke (ETS): A critical reappraisal
57. Körperlast an polychlorierten biphenylen im vollblut bei 7-10jährigen kindern in der umgebung einer sondermüllverbrennungsanlage
58. Misclassification of smoking in a follow-up population study in southern Germany
59. trans, trans-muconic acid as a biomarker of non-occupational environmental exposure to benzene
60. Gefahrgutrechtliche voraussetzung für den vetsand von diagnostischen proben, bakterienkulturen u.a. infektiösen materialien
61. EPIC-Germany - A source for studies into diet and risk of chronic disease
62. Sources of variance in 24-hour dietary recall data: Implications for nutrition study design and interpretation
63. Validation of a self-administered food-frequency questionnaire administered in the European Prospective Investigation into Cancer and Nutrition (EPIC) study: Comparison of energy, protein, and macronutrient intakes estimated with the doubly labeled water, urinary nitrogen, and repeated 24-h dietary recall methods
64. Empirical evidence of correlated biases in dietary assessment instruments and its implications
65. Urinary nitrogen output as a validity test in dietary surveys
66. Reference values for analytes of 24-h urine collections known to be complete
67. The use of 24-h urine samples and energy expenditure to validate dietary assessments
68. The doubly labelled water method for the measurement of energy expenditure in humans: Risks and benefits
69. The validity of self-reported energy intake as determined using the doubly water laballed technique
70. Comparison of self-reported alcohol intake with the urinary excretion of 5-hydroxytryptophol:5-hydroxyindole-3-acetic acid, a biomarker of recent alcohol intake
71. Urinary cotinine as a tobacco-smoke exposure index: A minireview
72. The validation of physical activity instruments for measuring energy expenditure: Problems and pitfalls
73. Reliability, validity, and methodological response to the assessment of physical activity via self-report
74. The assessment of physical activity in individuals and populations: Why try to be more precise about how physical activity is assessed?
75. Biochemical indicators of dietary intake
76. The role of pathologists in environmental medicine and public health
77. Invited commentary: "molecular epidemiology": New pathway or new travelling companion
78. Formation of a molecular epidemiology group?
79. Total energy intake: Implications for epidemiologic analyses